人类尿液中的thiuram火山化加速器及其人类暴露
Zhenling Fu1, Hangbiao Jin2, Weili Mao1
1Department of Pharmacy, Quzhou Affiliated Hospital of Wenzhou Medical University, Quzhou People's Hospital, Quzhou, Zhejiang, 324000, PR China.
Environmental research
|February 6, 2025
概括
蒂乌拉姆火山化加速器 (TVA) 广泛存在,在人类尿液中检测到了八种类型. 甲基二硫化物 (TMTD) 是最常见的,表明人类对这些添加剂的显著暴露.
科学领域:
- 环境化学环境化学
- 毒理学 毒理学 毒理学
- 人类暴露评估评估
背景情况:
- 蒂乌拉姆火山化加速器 (TVA) 在制造中被广泛使用.
- 之前的研究表明,人类通过尘埃样本广泛暴露于TVA.
- 人类尿液分析TVAs以前没有检查过,限制了暴露评估.
研究的目的:
- 综合分析人类尿液中十种类型的TVA的存在和含量.
- 用尿作为生物标志物来评估人类对TVA的暴露.
- 为了确定占主导地位的增值税,并评估人口差异的风险.
主要方法:
- 收集了中国昆州市201人尿液样本.
- 利用先进的分析技术检测和量化十种类型的TVA.
- 进行统计分析以比较性别之间的水平,并与年龄相关联.
主要成果:
- 在10个TVA中,有8个在人类尿样中检测到,检测率从14%到91%不等.
- 四甲基二硫化物 (TMTD),四甲基单硫化物 (TMTM) 和四甲基二硫化物 (TETD) 是最常见的.
- 男性的尿液中TETD和四甲基硫胺二硫化物 (TBTD) 含量高于女性;尿液TETD和TBTD与年龄负相关.
结论:
- 这项研究提供了人类尿液中TVA的首次全面评估.
- 尿液中的TVA水平证实了人类的广泛暴露,其中TMTD是主要分析剂.
- 调查结果强调需要进一步调查TVA暴露对健康的影响.
关键词:
人类暴露的人类暴露.人类尿液是人类的尿液.TMTTDD 这样就好了.TMTMTM TMTM TMTM TMTM TMTM TMTM TMTM TMTM TM TM TM TM TM TM TM TM TM TM TM TM TM TM TM TM TM TM TM TM TM TM TM TM TM TM TM TM TM TM TM TM TM TM TM TM TM TM TM TM TM TM TM TM TM TM TM TM TM TM TM TM TM TM TM TM TM TM TM TM TM TM TM TM TM TM TM TM TM TM TM TM TM TM TM TM TM TM TM TM TM TM TM TM TM蒂乌拉姆斯的火山化加速器相关概念视频
Mutations
33.3K
Mutations are changes in the sequence of DNA. These changes can occur spontaneously or they can be induced by exposure to environmental factors. Mutations can be characterized in a number of different ways: whether and how they alter the amino acid sequence of the protein, whether they occur over a small or large area of DNA, and whether they occur in somatic cells or germline cells.
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
33.3K
Drug Excretion: Miscellaneous Routes
34
Drug excretion involves various organs, including the liver, intestines, skin, and eyes. In the case of drugs or toxins, they can be actively secreted into bile by transporters in the hepatocyte's canalicular membrane. These substances enter the GI tract during digestion and may be reabsorbed into the body from the intestine. This process, known as enterohepatic recycling, can significantly prolong the presence and effects of a substance in the body. To interrupt this cycle, specific...
34
Renal Drug Excretion: Tubular Secretion
114
Active tubular secretion is a robust, energy-demanding process that utilizes carrier systems to transport drugs into renal tubules. The active renal secretion systems include the organic anion transporter (OAT) for weak acids and the organic cation transporter (OCT) for weak bases. Structurally similar drugs can compete for the same transporter, potentially leading to drug accumulation and toxicity. However, this principle can be exploited therapeutically. One example is probenecid (Probalan),...
114
Phase II Reactions: Glucuronidation
249
Glucuronidation, a pivotal phase II biotransformation process, involves the coupling of glucuronic acid to a drug or xenobiotic. Given its widespread occurrence and critical role in drug metabolism, it's considered the most crucial phase II reaction. It enhances the water solubility of substances, aiding their expulsion from the body. The driving force behind these reactions is a group of enzymes known as UDP-glucuronosyltransferases (UGTs). UGTs facilitate the transfer of a glucuronic acid...
249
Drug Elimination by Renal Route: Tubular Reabsorption
3.1K
During the process of renal excretion, as the glomerular filtrate progresses to the distal convoluted tubule (DCT), drugs that are highly permeable, lipophilic, and nonionized undergo passive reabsorption from the tubular fluid into the surrounding peritubular capillaries. This reabsorption process restricts their elimination through the kidneys. However, the majority of drugs are either weak acids or weak bases, and their ionization level is dependent on pH. By altering the pH of urine, the...
3.1K
Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation
135
Glutathione, a tripeptide made up of glutamate, cysteine, and glycine, is a critical player in the detoxification of drugs and xenobiotics via a process known as glutathione conjugation or mercapturic acid formation. This phase II biotransformation reaction involves the covalent binding of glutathione to a drug or its metabolite, enhancing the compound's water solubility and enabling its excretion.
Several distinctive characteristics distinguish glutathione conjugation from other phase II...
Several distinctive characteristics distinguish glutathione conjugation from other phase II...
135


